Home1099 • HKG
Follow
Sinopharm Group Co Ltd
Previous close
$20.40
Day range
$19.80 - $20.45
Year range
$17.44 - $28.45
Market cap
62.57B HKD
Avg Volume
4.12M
P/E ratio
6.37
Dividend yield
4.71%
Primary exchange
HKG
Market news
.INX
0.11%
0.12%
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 144.97B | 0.04% |
Operating expense | 7.21B | 1.69% |
Net income | 1.99B | -7.92% |
Net profit margin | 1.37 | -8.05% |
Earnings per share | — | — |
EBITDA | 5.22B | -9.65% |
Effective tax rate | 23.72% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 44.26B | 15.83% |
Total assets | 419.95B | 8.56% |
Total liabilities | 304.01B | 8.33% |
Total equity | 115.93B | — |
Shares outstanding | 3.12B | — |
Price to book | 0.89 | — |
Return on assets | 2.82% | — |
Return on capital | 5.72% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 1.99B | -7.92% |
Cash from operations | 3.66B | 27.61% |
Cash from investing | -1.17B | 16.95% |
Cash from financing | -3.61B | 24.78% |
Net change in cash | -1.12B | 66.33% |
Free cash flow | 14.96B | -27.03% |
About
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Founded
2003
Website
Employees
115,959